CLDX — Celldex Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapNeutral

Annual balance sheet for Celldex Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	194	408	305	424	725
Net Total Accounts Receivable
Net Total Receivables	1.8	0.172	0.347	2.63	0.7
Prepaid Expenses
Total Current Assets	198	411	318	432	747
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	7.26	6.52	7.75	6.64	8.24
Net Intangible Assets
Other Long Term Assets
Total Assets	236	445	353	466	792
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	14.2	16.5	18.6	31.1	39.5
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	26.5	25.2	26.5	36.5	45.3
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Unrealized Gain / Loss
Other Equity
Total Equity	209	419	326	429	747
Total Liabilities & Shareholders' Equity	236	445	353	466	792
Total Common Shares Outstanding